FOLH1 and posterior cortical atrophy: Positron emission tomography (PET) imaging radioligands targeting PSMA have quickly become the standard of care diagnostic tool in managing biochemically recurrent PCa, demonstrating superiority to traditional imaging techniques such as bone scintigraphy with a computed tomography (CT) scan [9–11].